Pubblicazioni

Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis. A post hoc analysis of the SUPREME study

2021 - ACTA DERMATO-VENEREOLOGICA

Talamonti, M; Malara, G; Natalini, Y; Bardazzi, F; Conti, A; Chiricozzi, A; Mugheddu, C; Gisondi, P; Piaserico, S; Pagnanelli, G; Amerio, P; Potenza, C; Cantoresi, F; Fargnoli, Mc; Balato, A; Loconsole, F; Offidani, A; Bonifati, C; Prignano, F; Bartezaghi, M; Rausa, A; Aloisi, E; Orsenigo, R; Costanzo, A; the SUPREME Study, Group. Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: an item response theory analysis

2021 - PEERJ

Liuzza, MARCO TULLIO; Spagnuolo, Rocco; Antonucci, Gabriella; Daniela Grembiale, Rosa; Cosco, Cristina; Salvatore Iaquinta, Francesco; Funari, Vanessa; Dastoli, Stefano; Steven, Nistico; Doldo, Patrizia

Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity

2021 - ARCHIVES OF DERMATOLOGICAL RESEARCH

Esposito, M.; Giunta, A.; Nanni, R. C.; Criscuolo, S.; Manfreda, V.; Del Duca, E.; Bianchi, L.; Troisi, A.